Medicis (MRX) Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine 2/3/2010
More...
|
L'OREAL and Hurel Corporation Announce R&D Collaboration to Develop a Non-Animal Alternative, Microfluidic Biochip 1/14/2010
More...
|
Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001 1/5/2010
More...
|
Fibrocell Science, Inc. Receives FDA Complete Response Letter Regarding azficel-T for Wrinkles; Additional Data Needed Prior to Approval 12/22/2009
More...
|
Ranbaxy Laboratories Recalls Skin Infection Drug, Sotret in the U.S. 11/20/2009
More...
|
Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials 10/29/2009
More...
|
Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles 10/12/2009
More...
|
Allergan Inc. (AGN)'s Botox Reduces Migraine Headache Days 9/11/2009
More...
|
Bayer HealthCare AG (BAY) Acquires Two Prescription Dermatology Product Lines From SkinMedica, Inc. in the U.S. 9/2/2009
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) and Megapharm Enter Into Distribution and Supply Agreement for EpiCeram 7/27/2009
More...
|
SkinMedica, Inc. to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 5/11/2009
More...
|
GlaxoSmithKline (GSK) to Buy Stiefel Laboratories for Up to $3.6 Billion 4/20/2009
More...
|
PPD, Inc. (PPDI) Acquires Magen Biosciences; Expands PPD's Compound Partnering Program Into Dermatology 4/3/2009
More...
|
Nurses' Skin Care Dream Becomes Reality with L'Athene 12/16/2008
More...
|
Let Yourself Glow - Holiday Skin Tips 12/15/2008
More...
|
More Hope In A Jar? The Anti-Aging Skin Care Promise 12/10/2008
More...
|
Basilea Pharmaceutica Release: Zevtera(TM) (Ceftobiprole Medocaril), The Novel Anti-MRSA Broad-Spectrum Antibiotic, Receives A Positive Opinion From The CHMP 11/21/2008
More...
|
Valeant Pharmaceuticals International (VRX) Acquires DermTech International for Approximately AU$19 Million; Purchase Expands Valeant's Dermatology Business in Australia 11/14/2008
More...
|
Medicis (MRX) Shares Fell Thursday By Continued Economic, Generic Concerns 11/14/2008
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Sponsors “Walk a Mile in My Shoes” for National Epidermolysis Bullosa Awareness Week 10/24/2008
More...
|
Targanta Therapeutics Releases Results from Phase 2 SIMPLIFI Study Evaluating Single or Infrequent Doses of Oritavancin 10/22/2008
More...
|
LEDs May Help Reduce Skin Wrinkles, University of Ulm Researchers Report 10/21/2008
More...
|
Study Backs Laser Treatment For Sun-Damaged Skin, University of Michigan Medical School 10/21/2008
More...
|
British Association of Dermatologists Doctors Warn Of Rash From Mobile Phone Use 10/17/2008
More...
|
Medicis (MRX) Announces FDA Approval of PMA Supplement for RESTYLANE 10/10/2008
More...
|
Antioxidant Cream Guards Skin From UV Damage, Duke University Medical Center Study 9/19/2008
More...
|
Estrogen Cream Flunks Sun Damage Test, University of Michigan Study Finds 9/16/2008
More...
|
Isolagen, Inc. (ILE)'s Cell Therapy Treatment For Wrinkles Shows Promise 8/19/2008
More...
|
Moisturizers Increased Non-Melanoma Skin Cancers In Mice, Rutgers University Study Shows 8/15/2008
More...
|
Widely Prescribed Anti-parasite Drug Targets Cancer-causing Protein, New York University Cancer Institute and the Ronald O. Perelman Department of Dermatology Study 8/13/2008
More...
|
Serentis Expands Series A Financing 8/12/2008
More...
|
Rubbery Conductor Promises Robots A Stretchy Skin, University of Tokyo Research 8/8/2008
More...
|
Cocoa Butter Lotion Won't Prevent Stretch Marks, American University of Beirut Medical Center Study 8/6/2008
More...
|
PhotoMedex, Inc. (PHMD) to Acquire Photo Therapeutics, Expand Global Dermatology Presence 8/5/2008
More...
|
Obagi Medical Products, Inc. (OMPI) Presents In Vitro Data Showing its Topical Vitamin C Serums Provide Greater Absorption and Stability Than a Leading Competitor 7/31/2008
More...
|
DUSA Pharmaceuticals (DUSA) Announces Update on Nicomide(R); Company Places Voluntary Hold on Existing Inventory 7/18/2008
More...
|
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Announces Advancements in Dermatology Program 7/17/2008
More...
|
Highly Advanced Biotechnology from SkinCareRX Gives People Ability to Repair Years of Sun Damage at the DNA Level 7/1/2008
More...
|
Lutronic, Inc. Announces FDAClearance of its Spectra VRM III Q-Switched Nd:Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions 5/23/2008
More...
|
Lutronic USA LLC Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd:Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions 5/21/2008
More...
|
Vall d'Hebron University Hospital and Autonomous University Study Raises Questions About A Facial Implant 5/20/2008
More...
|
Anacor Pharmaceuticals, Inc. to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference 5/8/2008
More...
|
'Tiny Radio Antennas' Under Skin Could Act As Remote Sensors Of Humans' Emotional, Physiological State 4/30/2008
More...
|
Cosmo Pharmaceuticals S.p.A. Initiates Phase I Trials of CB-03-01 for the Treatment of Skin Disorders
4/1/2008
More...
|
Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 3/19/2008
More...
|
Johnson and Johnson Pharmaceutical R&D (NJ), Basilea Pharmaceutica Key Drug Fails to Get FDA Approval; Stock Dives 3/18/2008
More...
|
Baxter International, Inc. (BAX) Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously 3/17/2008
More...
|
Isolagen, Inc. (ILE) Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 3/14/2008
More...
|
European Medicines Evaluation Agency Grants Clinuvel Two Orphan Drug Designations 3/13/2008
More...
|
Derma Sciences, Inc. (DSCI) Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference 3/10/2008
More...
|
Theravance, Inc. (THRX) Receives Additional Information Regarding FDA Cancellation of Advisory Committee Meeting 3/4/2008
More...
|
OrthoLogic Corporation (OLGC) Announces Initiation of Dosing for AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring 2/29/2008
More...
|
How Skin Color Is Determined 2/27/2008
More...
|
Senetek PLC (SNTK) Release: Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology 2/26/2008
More...
|
Protein Maintains Cross Talk Between Cells That Control Hair Growth 2/20/2008
More...
|
JADO Technologies Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis 2/18/2008
More...
|
Warning Over Illegal Skin Bleach 2/15/2008
More...
|
Pepper May Help Disfiguring Skin Condition 2/14/2008
More...
|
BIOLASE Technology, Inc. (BLTI) Announces FDA 510(k) Clearance of Its Waterlase(R) MD Laser System for Dermatology 2/7/2008
More...
|
Scar-free Healing Shown With Gene Suppression 1/24/2008
More...
|
EpiCept Corporation (EPCT) Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream 1/23/2008
More...
|
University of Southern California: Mechanism That Controls Activation Of Stem Cells During Hair Regeneration Identified 1/21/2008
More...
|
Hatchtech to Go to Phase II Trial 1/21/2008
More...
|
San Francisco Bay Area Has First Major U.S. Study Of Morgellons Disease 1/17/2008
More...
|
Pachyonychia Project Release: Clinical Trial to Treat Rare Skin Disorder With siRNA Technology 1/17/2008
More...
|
Isolagen, Inc. (ILE) Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies 1/15/2008
More...
|
Sol-Gel Signs $24.7 M Deal for Dermatology Drug Delivery 1/8/2008
More...
|
New Ingredients in Drug-Like Anti-Aging Products Improve Skin 12/31/2007
More...
|
Lymphoma Drug Used To Treat Skin Disorders 12/18/2007
More...
|
BioLineRx Ltd. Signed Exclusive License Agreement with Innovative Pharmaceutical Concepts; In-Licenses Novel Formulation BL-5010 for the Non-Surgical Removal of Skin Lesions 12/10/2007
More...
|
Natural Compound in Broccoli Could Treat Devastating Genetic Skin Disorder 12/3/2007
More...
|
Anika Therapeutics (ANIK) Ends License Agreement with Galderma Laboratories for Elevess 11/21/2007
More...
|
Genzyme Corporation (GENZ)'s Epicel(TM) Wins Marketing Approval for Severe Burn Victims 10/29/2007
More...
|
FDA Asks for More Information to OK Theravance, Inc. (THRX) Skin Disease Drug 10/22/2007
More...
|
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan Plans to Move Forward with Phase III 10/17/2007
More...
|
Innocoll, Inc. Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns 10/17/2007
More...
|
MIGENIX Inc. (MGI.TO) Omiganan Phase II Rosacea Study Demonstrates Promising Results Partner Plans to Advance to Phase III 10/17/2007
More...
|
E-Z-EM (EZM) Receives Additional Orders for RSDL from U.S. Department of Defense 10/1/2007
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Drug Fails in Rosacea Study 9/26/2007
More...
|
Synthetic Lipids Used Against Skin Disease 8/30/2007
More...
|
Pacific Bioscience Laboratories Inc. Issues Voluntary Safety Recall of Clarisonic(R) Skin Care System 8/30/2007
More...
|
Natural Chemical Found in Broccoli Helps Combat Skin Blistering Disease, Johns Hopkins University School of Medicine Study 8/27/2007
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema 8/23/2007
More...
|
AGI Dermatics: Demand for DNA Repair Formula Drives Growth of Remergent(R) Brand 8/21/2007
More...
|
ULURU Inc. Announces the Commencement of a Clinical Study in Burn Patients 7/26/2007
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Receives FDA Clearance of Antimicrobial Barrier Topical Cream 7/20/2007
More...
|
Peplin Limited (PEP.AX) Positive Preliminary Results of Phase IIb AK Study 7/19/2007
More...
|
New Galderma Laboratories Quality Report Reveals New Trends for Dermatology Professionals and Managed Care Providers 7/17/2007
More...
|
Sciton Inc. Receives FDA Clearance for Laser-Assisted Lipolysis and Pulsed Light Wrinkle Treatment 7/12/2007
More...
|
Senetek PLC (SNTK) Announces Update On Invicorp(R) 7/9/2007
More...
|
Bradley Pharmaceuticals (BDY) Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM) 6/28/2007
More...
|
Phosphagenics Limited (POH.AX) Announces Positive Proof of Concept Results from Studies Utilizing Company's Dermal Drug Delivery Technology 6/25/2007
More...
|
Shire Pharmaceuticals (SHPGY) In-Licenses JUVISTA(R) (Human TGFbeta3) From Renovo Ltd.; Shire to Pay Up to $825 Million 6/20/2007
More...
|
Auriga Laboratories, Inc. (ARGA.OB) Announces the Formation of A.T.S. Pharmaceuticals, a Specialty Division Dedicated to Dermatology and Gastroenterology 6/20/2007
More...
|
National Institutes of Health (NIH): Researchers Discover Gene For Rare Skin Disorder 6/20/2007
More...
|
Advanced Viral Research Corp. (ADVR) Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study 6/18/2007
More...
|
Barrier Therapeutics, Inc. (BTRX) Says Liarozole Phase 2/3 Study Misses Goal, Shares Fall 6/14/2007
More...
|
Astion Pharma Gets DKK 50 Million to Accelerate Phase III of its Drug Candidate ASF-1096 6/13/2007
More...
|
Avicena Group, Inc.'s Proprietary Dermaceutical Compound to be Subject of Presentation at the Strategic Research Institute's 4th Annual Cosmeceuticals Conference 6/11/2007
More...
|
Bradley Pharmaceuticals (BDY) Solaraze(R) and TX Systems(R) B-Lift(R) Featured at European Dermatology Conference 5/30/2007
More...
|
Bradley Pharmaceuticals (BDY) Skin Cancer Screening Tour Encourages Visits to Dermatologists 5/25/2007
More...
|
Auriga Laboratories, Inc. (ARGA.OB) Acquires Exclusive License to Market Unique New Intranasal Lubricant 5/24/2007
More...
|
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology 4/23/2007
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Announces New Publication of Scientific Research on Ceragenin(TM) Technology 4/23/2007
More...
|
"Instant Face Lift" Chemical DMAE Damages Skin Cells 4/18/2007
More...
|
GlaxoSmithKline (GSK) Announces FDA Approval of Altabax(TM) (Retapamulin Ointment), 1% 4/13/2007
More...
|
Anika Therapeutics (ANIK) Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma Laboratories 4/13/2007
More...
|
Anti-Wrinkle Compound Causes Pathological Reaction in Skin Cells 4/12/2007
More...
|
Reliant Technologies, Inc. Announces Over $1 Million Joint Research and Development Program with Massachusetts General Hospital 4/10/2007
More...
|
Minnesota Partnership Researchers Discover Disease 'Fingerprint' 4/5/2007
More...
|
Candela (CLZR) Release: Vbeam(R) Laser Provides Safe and Effective Treatment for Debilitating Skin Disorder 4/4/2007
More...
|
Smoking Associated with Aging of Nonfacial Skin 3/20/2007
More...
|
Theravance, Inc. (THRX) Announces FDA Acceptance Of Telavancin NDA; Triggering Milestone Payment Of $31 Million 2/21/2007
More...
|
Virabiotics's MolluscuDerm(TM) Topical Antiviral Therapy Launches At American Academy of Dermatology Meeting Feb. 2-5, 2007 1/31/2007
More...
|
Galderma Laboratories Introduces New Kit For Rosacea Treatment 1/12/2007
More...
|
Foamix And Intendis, Inc. Sign License Agreement For The Development Of A Dermatological Foam 1/10/2007
More...
|
DUSA Pharmaceuticals (DUSA) Announces Exclusive Agreement With Daewoong Pharmaceutical Co., Ltd. To Market DUSA's Levulan'R' Kerastick'R' For Photodynamic Therapy In Asian Territories 1/8/2007
More...
|
QLT USA, Inc. Receives Final Payment For Generic Dermatology And Manufacturing Business 1/4/2007
More...
|
Stiefel Laboratories Completes Acquisition Of Connetics Corporation (CNCT) 12/29/2006
More...
|
FDA Approves BioForm Medical, Inc.'s Radiesse(R) Facial Filler For Two New Aesthetic Indications 12/27/2006
More...
|
Anika Therapeutics (ANIK) Receives FDA Approval For Its Cosmetic Tissue Augmentation Product 12/21/2006
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Signs License And Supply Agreement with MediGene For Marketing Rights To Oracea In EU And Certain Other Countries 12/20/2006
More...
|
Helix Biopharma (CC:HBP) Initiates Enrollment In Phase II Clinical Trial With Topical Interferon Alpha-2b In Patients With Ano-Genital Warts 12/11/2006
More...
|
Amarillo Biosciences (AMAR) Announces Phase II Study Of Orally Administered Interferon Alpha In The Treatment Of Oral Warts In HIV-Positive Patients 12/11/2006
More...
|
FDA Warns Five Firms To Stop Compounding Topical Anesthetic Creams 12/8/2006
More...
|
Gel-Del TechnologiesRelease: New Alternative To Wrinkle Treatment In Clinical Trials 12/5/2006
More...
|
Glucocorticoid Plays Key Role In Skin Abnormalities Induced By Psychological Stress 12/1/2006
More...
|
Advanced Viral Research Corp. (ADVR) Files An Amendment To Its Existing IND To Include Topical And Intralesional Therapy 11/14/2006
More...
|
Auriga Laboratories, Inc. (ARGA.OB) Expands Brand Portfolio With Exclusive Licensing Of Five Prescription Dermatology Products From River's Edge Pharmaceuticals 10/20/2006
More...
|
Dust Mites Disrupt Protective Function In Skin 9/29/2006
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Webcast Of Conference Call To Discuss Preliminary Results Of Phase 2 Dermatology Study 9/21/2006
More...
|
Connetics Corporation (CNCT) Reports Positive Results From Second Phase III Clinical Trial Of Extina(R) (Ketoconazole) Foam, 2% 8/28/2006
More...
|
Theravance, Inc. (THRX) Announces Positive Results In Phase 3 Telavancin Complicated Skin And Skin Structure Infection Program; Trials Achieve Goal 8/23/2006
More...
|
Portfolio-Company, Revotar Biopharmaceuticals Concludes Start-Up Development Agreement With US Pharmaceuticals Manufacturer 8/22/2006
More...
|
ArteFill, The Permanent Wrinkle-Eraser? 8/18/2006
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Provides Mid-Year Update; Company Commencing Post-510k Clearance Studies For EpiCeram(R) To Support Current Partnering Discussions 8/3/2006
More...
|
Infinity Venture Capital Leads US $4.5 Million Round In Applisonix 8/1/2006
More...
|
FDA Approves A New Over-The-Counter Sunscreen Product 7/24/2006
More...
|
Scientists Decode How Plants Avoid Sunburn 7/20/2006
More...
|
Rubbing Sunscreen Into Skin Reduces Its Effectiveness 7/18/2006
More...
|
Curis, Inc. (CRIS) Provides Update On Basal Cell Carcinoma Phase I Clinical Trial; Company To Halt Skin Cancer Drug Trial In Current Formulation 7/12/2006
More...
|
ZARS Pharma Announces FDA Approval Of A Topical Local Anesthetic Peel 7/7/2006
More...
|
Coloplast New Study Shows That Needless Suffering Of Ostomy Patients May Be Avoided 7/5/2006
More...
|
Bradley Pharmaceuticals (BDY) Release: FDA Extends PDUFA Date For Polyphenon(R) E Ointment To October 31, 2006 6/30/2006
More...
|
Hopkins Researchers Develop New Quick Tool To Sort Out Insect Bites In Children 6/29/2006
More...
|
Microscopic Scaffolding Offers A 'Simple' Solution To Treating Skin Injuries 6/27/2006
More...
|
Sontra Medical Signs Distribution Agreement wWth Korean Distributor JOYMG For SonoPrep(R) Skin Permeation System 6/26/2006
More...
|
SkinMedica Announces New Debt Facility And FDA Acceptance Of Its New Drug Application For Desonate(TM) 6/22/2006
More...
|
EMEA Grants Cellerix, S.L. Orphan Drug Status To CX501 For The Treatment Of Epidermolysis Bullosa 6/14/2006
More...
|
Allergan Inc. (AGN) Announces FDA Approval Of Juvederm(R) 6/5/2006
More...
|
Fougera (AAA) First-To-Market With Metronidazole Lotion 0.75% (Rx) 5/24/2006
More...
|
Avicena Group, Inc.'s Nurigene(TM) Product Line Demonstrates Significant Anti-Aging Properties In Clinical Study 5/23/2006
More...
|
QLT Inc. (QLTI) Delays Initiation Of Phase IIa Atrigel/Octreotide Program 5/19/2006
More...
|
Flavonol-Rich Chocolate Could Improve Skin From Within 5/16/2006
More...
|
NicOx SA (NCOX.F) And Grupo Ferrer Internacional S.A. Select Candidate For Development In Dermatology Collaboration 5/16/2006
More...
|
Seattle Genetics, Inc. (SGEN) Reports On SGN-30 Cutaneous ALCL Phase II Clinical Trial At The Society Of Investigative Dermatology Meeting 5/4/2006
More...
|
Advanced Cell Technology Announces Collaboration With Xgene Corporation To Assess Its Dermal Cell Technologies In Human Skin Models 4/28/2006
More...
|
Onset Therapeutics Announces Company Launch 4/26/2006
More...
|
Antares Pharma, Inc. (ANTR) Announces New Proprietary Dermatological Drug Delivery System 4/24/2006
More...
|
Cephalon, Inc. (CEPH) Says Sparlon Skin Rash Not SJ Syndrome 4/19/2006
More...
|
New Antimicrobial Compound Adheres To Skin To Promote Healing 4/13/2006
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Receives 510k Clearance Of EpiCeram(R) For The Treatment Of Atopic Dermatitis And Other Skin Disorders 4/12/2006
More...
|
Sunscreen Chemicals Disrupt Thyroid In Rats 4/3/2006
More...
|
Cephalon, Inc. (CEPH) Drug A Victim Of ADHD Debate: Experts 3/30/2006
More...
|
Anti-Wrinkle Company, Artes Medical Inc. Gets $50 Million Series E 3/30/2006
More...
|
Potential Association Between Skin Cancer Cream And Improvements Of Prematurely Aged Skin 3/6/2006
More...
|
Medicis Pharmaceutical (MRX) Says Skin Drug Gets Added FDA Approval 3/3/2006
More...
|
Inamed Corporation (IMDC)'s Phase 3 Study Results For Juvederm(TM) To Be Presented At The 64th Annual Meeting Of The American Academy Of Dermatology 3/3/2006
More...
|
DUSA Pharmaceuticals (DUSA) Reports Statistically Significant Results From Phase II Clinical Trial 2/24/2006
More...
|
University of Wisconsin-Madison Scientists Find A Way To Make Human Collagen In The Lab 2/14/2006
More...
|
MediGene AG (DX:MDG) And Bradley Pharmaceuticals (BDY) Enter Marketing And Development Partnership For Polyphenon(R) E Ointment 1/31/2006
More...
|
Warnings Required On Two Novartis Corporation (NVS) And Astellas Pharma Inc. Eczema Drugs Says FDA 1/20/2006
More...
|
Perrigo Company (PRGO) Announces FDA Approval For Desoximetasone Gel 1/11/2006
More...
|
MIGENIX Inc. (MGI.TO) Completes License Agreement For MX-594AN; Establishes Broad Dermatology Alliance With Cutanea Life Sciences, Inc.
12/8/2005
More...
|
"Fragile Skin Gene" Killed Baby 11/21/2005
More...
|
ProtoKinetix Inc. (PKTX.OB) AAGP(TM) Series Of Trials For Cosmetic Applications Now Completed 11/17/2005
More...
|
Taro Pharmaceutical Industries Ltd. (TARO) To Initiate Phase III Clinical Trial In The U.S. Of Novel Ovide(R) Formulation for Control of Head Lice 10/27/2005
More...
|
SkinMedica Withdraws IPO, Cites Market Conditions 10/21/2005
More...
|
PharmaDerm Launches CUTIVATE(R) Lotion 10/17/2005
More...
|
Jefferson Scientists Identify Gene Defect Leading To Abnormal Skin Development And Cancer 10/3/2005
More...
|
CollaGenex Pharmaceuticals, Inc.'s (CGPI) New Drug Application For ORACEA(R) Accepted For Review By FDA 10/3/2005
More...
|
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Submits 510(k) Application To FDA For Epiceram(TM) 9/26/2005
More...
|
Spray-On Skin Brings Hope To Burns Victims 9/6/2005
More...
|
Alpharma Inc. (ALO) Launches Halobetasol Propionate Ointment 9/1/2005
More...
|
Altachem Pharma Ltd. (AAF.V) Receives Health Canada Clearance To Initiate Phase I Clinical Trial For Actinic Keratosis 9/1/2005
More...
|
Curis, Inc. (CRIS) Release: Hedgehog Agonists Modulate Hair Growth; Preclinical Data Published In The Journal Of Investigational Dermatology 9/1/2005
More...
|
Pfizer Japan Inc. Releases OTC Topical Drug 8/29/2005
More...
|
Master Gene For Skin May Hold Key To Youth 8/17/2005
More...
|
Immusol, Inc. Announces Collaboration With Novartis Corporation (NVS) 8/16/2005
More...
|
Connetics Corporation (CNCT) Reports Positive Results From Desilux Phase III Trial; NDA Submission Anticipated By Year End For First Drug Using Patented Emollient Foam Technology 8/15/2005
More...
|
Senetek PLC (SNTK) Guaranteed $37 Million Over Five Years For Expanded Kinetin Rights And Exclusive Zeatin License 8/9/2005
More...
|
Intercytex Limited Raises £12 Million In Financing Round 8/2/2005
More...
|
Positive Results Of CollaGenex Pharmaceuticals, Inc.'s (CGPI) Phase 2 Clinical Study Evaluating Effects Of COL-3 For Treating Rosacea Presented At North Carolina Dermatology Association 8/2/2005
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Files New Drug Application For Oracea 8/1/2005
More...
|
York Pharma PLC (YRK) Announces The First Regulatory Filing For Its Lead Product, Abasol (TM) 7/29/2005
More...
|
Spanish Biotechnology Company, Cellerix, S.L., Receives Orphan Status Designation By The European Medicines Evaluation Agency For A Stem Cell Medicinal Product 7/29/2005
More...
|
Botox Injections Fight Underarm Sweat 7/27/2005
More...
|
AnGes MG Inc. To Start Phase I Clinical Trial Of NF-kappa B Decoy Oligodeoxynucleotide For Atopic Dermatitis 7/26/2005
More...
|
Positive Results Of CollaGenex Pharmaceuticals, Inc.'s (CGPI) Phase 3 Clinical Studies Evaluating Effects Of Oracea (Doxycycline Controlled Release Capsules) As Treatment For Rosacea Presented At Summer Meeting Of The American Academy of Dermatology 7/25/2005
More...
|
Foamix's PerFoam(TM) For The Treatment Of Lice Demonstrates Safety And 96% Efficacy In Phase II/III Study 7/18/2005
More...
|